[
    [
        {
            "time": "2023-09-16",
            "original_text": "A股共发生170宗大宗交易成交38.33亿元（9月16日）",
            "features": {
                "keywords": [
                    "大宗交易",
                    "A股",
                    "成交额"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股共发生170宗大宗交易成交38.33亿元（9月16日）",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "复星医药今日大宗交易成交326.90万股，成交价57.51元溢价0.0%",
            "features": {
                "keywords": [
                    "复星医药",
                    "大宗交易",
                    "溢价"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药今日大宗交易成交326.90万股，成交价57.51元溢价0.0%",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "复星医药：为控股子公司提供担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "担保"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药：为控股子公司提供担保",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "复星医药：控股子公司获药品注册申请受理",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "药品注册",
                    "受理"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：控股子公司获药品注册申请受理",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "复星医药2196｜完成发行12亿人民币超短期融资券 利率2.6% | 头条金融网",
            "features": {
                "keywords": [
                    "复星医药",
                    "融资券",
                    "利率"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药2196｜完成发行12亿人民币超短期融资券 利率2.6% | 头条金融网",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "复星医药(600196.SH)：子公司斯鲁利单抗注射液联合化疗等获药品注册申请受理",
            "features": {
                "keywords": [
                    "复星医药",
                    "斯鲁利单抗",
                    "药品注册",
                    "受理"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：子公司斯鲁利单抗注射液联合化疗等获药品注册申请受理",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "复星医药：拟为控股子公司FMH提供不超过3850万欧元担保 大额借贷担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "子公司",
                    "担保",
                    "借贷"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药：拟为控股子公司FMH提供不超过3850万欧元担保 大额借贷担保",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "复星医药：斯鲁利单抗注射液联合卡铂和白蛋白紫杉醇一线治疗局部晚期或转移性鳞状非小细胞肺癌获国家药品监督管理局药品注册申请审评受理",
            "features": {
                "keywords": [
                    "复星医药",
                    "斯鲁利单抗",
                    "药品注册",
                    "受理"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：斯鲁利单抗注射液联合卡铂和白蛋白紫杉醇一线治疗局部晚期或转移性鳞状非小细胞肺癌获国家药品监督管理局药品注册申请审评受理",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 10,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "干货！发改委发布会：保供稳价、粮食安全、猪肉收储",
            "features": {
                "keywords": [
                    "发改委",
                    "保供稳价",
                    "粮食安全",
                    "猪肉收储"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "农业",
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "干货！发改委发布会：保供稳价、粮食安全、猪肉收储",
                "Correlation": 1,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 2,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "复星医药：斯鲁利单抗注射液第二个适应症获注册申请受理",
            "features": {
                "keywords": [
                    "复星医药",
                    "斯鲁利单抗",
                    "药品注册",
                    "受理"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药：斯鲁利单抗注射液第二个适应症获注册申请受理",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-09-18",
            "original_text": "大行评级 | 大摩：美10年期债息回升，复星医药(2196.HK)等股对此敏感",
            "features": {
                "keywords": [
                    "复星医药",
                    "10年期债息",
                    "敏感"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "大行评级 | 大摩：美10年期债息回升，复星医药(2196.HK)等股对此敏感",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]